KORU Medical Systems, Inc. (NASDAQ:KRMD) Receives $5.88 Average PT from Analysts

KORU Medical Systems, Inc. (NASDAQ:KRMD) has been assigned a consensus recommendation of “Moderate Buy” from the six brokerages that are presently covering the firm, MarketBeat Ratings reports. One equities research analyst has rated the stock with a sell rating, one has assigned a hold rating, three have assigned a buy rating and one has assigned a strong buy rating to the company. The average twelve-month target price among brokers that have issued ratings on the stock in the last year is $6.1250.

A number of brokerages have recently commented on KRMD. Craig Hallum reissued a “buy” rating and set a $7.00 price target on shares of KORU Medical Systems in a research note on Tuesday. Wall Street Zen raised shares of KORU Medical Systems from a “buy” rating to a “strong-buy” rating in a research note on Monday, January 12th. Lake Street Capital boosted their price objective on shares of KORU Medical Systems from $6.00 to $8.00 and gave the stock a “buy” rating in a research note on Monday, December 22nd. Canaccord Genuity Group raised their target price on KORU Medical Systems from $5.00 to $6.00 and gave the stock a “buy” rating in a research report on Wednesday, December 17th. Finally, Weiss Ratings reiterated a “sell (d-)” rating on shares of KORU Medical Systems in a report on Wednesday, October 8th.

Institutional Inflows and Outflows

Hedge funds and other institutional investors have recently made changes to their positions in the business. Police & Firemen s Retirement System of New Jersey bought a new stake in shares of KORU Medical Systems in the 2nd quarter valued at $30,000. BNP Paribas Financial Markets increased its stake in KORU Medical Systems by 52.1% in the third quarter. BNP Paribas Financial Markets now owns 10,148 shares of the company’s stock valued at $39,000 after purchasing an additional 3,478 shares in the last quarter. Lazard Asset Management LLC acquired a new position in shares of KORU Medical Systems during the second quarter valued at about $59,000. Acadian Asset Management LLC bought a new position in shares of KORU Medical Systems during the 1st quarter worth about $63,000. Finally, Intech Investment Management LLC acquired a new stake in shares of KORU Medical Systems in the 2nd quarter valued at about $73,000. 58.60% of the stock is owned by institutional investors and hedge funds.

KORU Medical Systems Trading Down 2.8%

Shares of KORU Medical Systems stock opened at $5.51 on Friday. The firm has a market capitalization of $255.24 million, a PE ratio of -68.88 and a beta of 0.51. The company has a current ratio of 2.48, a quick ratio of 1.92 and a debt-to-equity ratio of 0.01. The firm’s 50 day moving average is $5.47 and its 200 day moving average is $4.45. KORU Medical Systems has a 1 year low of $1.86 and a 1 year high of $6.61.

KORU Medical Systems Company Profile

KORU Medical Systems, Inc develops and manufactures medical devices and supplies in the United States and internationally. It offers the freedom infusion systems to deliver life-saving therapies to patients with chronic illnesses, such as primary immunodeficiency diseases, chronic inflammatory demyelinating polyneuropathy, and paroxysmal nocturnal hemoglobinuria. Its products include the FREEDOM60 syringe infusion system, the FreedomEdge syringe driver, HIgH-Flo subcutaneous safety needle sets, and precision flow rate tubing products.